Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.M511181200 on October 17, 2005

J. Biol. Chem., Vol. 280, Issue 50, 41366-41372, December 16, 2005
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/50/41366    most recent
M511181200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Béve, J.
Right arrow Articles by Gustafsson, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Béve, J.
Right arrow Articles by Gustafsson, C. M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Structural and Functional Role of Med5 in the Yeast Mediator Tail Module*

Jenny Béve{ddagger}, Guo-Zhen Hu¶||, Lawrence C. Myers§, Darius Balciunas¶||1, Olivera Werngren{ddagger}, Kjell Hultenby**, Rolf Wibom{ddagger}, Hans Ronne¶||, and Claes M. Gustafsson{ddagger}2

From the {ddagger}Division of Metabolic Diseases and **Clinical Research Center, Karolinska Institutet, Novum, Karolinska University Hospital, SE-141 86 Stockholm, Sweden, the Department of Medical Biochemistry and Microbiology, Uppsala University, Box 582, SE-751 23 Uppsala, Sweden, the ||Department of Plant Biology and Forest Genetics, Uppsala Genetic Center, Swedish University of Agricultural Sciences, Box 7080, SE-750 07 Uppsala, Sweden, and the §Department of Biochemistry, Dartmouth Medical School, Hanover, New Hampshire 03755-3844

Received for publication, October 13, 2005


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Med5 (Nut1) is identified here as a component of the Mediator tail region. Med5 is positioned peripherally to Med16 (Sin4) together with the three members of the putative Gal11 module, Med15 (Gal11), Med2, and Med3 (Pgd1). The biochemical analysis receives support from genetic interactions between med5{Delta} and med15{Delta} deletions. The med5{Delta} and med16{Delta} deletion strains share many phenotypes, including effects on mitochondrial function with enhanced growth on nonfermentable carbon sources, increased citrate synthase activity, and increased oxygen consumption. Deletion of the MED5 gene leads to increased transcription of nuclear genes encoding components of the oxidative phosphorylation machinery, whereas mitochondrial genes encoding components of the same machinery are down-regulated. We discuss a possible role for Med5 in coordinating nuclear and mitochondrial gene transcription.


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The multiprotein Mediator complex is required for basal and regulated expression of nearly all RNA polymerase II (pol II)3-dependent genes in the Saccharomyces cerevisiae genome. Mediator conveys regulatory information from enhancers and other control elements to the promoter (1). The functional activities identified for Mediator include stimulation of basal transcription, support of activated transcription, and enhancement of phosphorylation of the C-terminal domain of pol II by the transcription factor IIH kinase (2, 3). S. cerevisiae Mediator also contains a histone acetyltransferase (HAT) activity, which is not found in other eukaryotic Mediator complexes (4). The HAT activity was localized to Med5 (Nut1), a S. cerevisiae-specific protein, which lacks homologues in higher eukaryotes (4, 5). The MED5 gene was originally isolated in a screen for mutants that would suppress the Swi4/Swi6 dependence of a synthetic reporter gene containing part of the HO promoter (6). Several other genes encoding Mediator proteins were identified in the same screen, including MED10 (NUT2), MED16 (SIN4), MED19 (ROX3), MED12 (SRB8), MED13 (SRB9), CDK8 (SRB10), and CYCC (SRB11). The MED5 gene is nonessential in yeast. A deletion of MED5 relieves repression at the URS2 element in the HO promoter but only in combination with a mutant allele of either MED10 or CCR4 (6). These effects on the HO promoter were seen with a lacZ reporter gene but not at the endogenous HO gene locus. The in vivo role of Med5 in Mediator-dependent gene expression therefore remains an open question.

In the presence of RNA pol II, Mediator adopts an extended conformation that embraces the globular pol II core complex (7). The extended structure reveals three distinct submodules of Mediator. Direct contacts are formed between pol II and the head and middle region (7, 8). The largest part of Mediator is made up of an elongated tail region, which does not appear to contact pol II. Structural analysis of mutant Mediator complex has demonstrated that the tail region contains the Med2, Med3, Med15 (Gal11), and Med16, proteins, which are involved in interactions with a number of different activators, including Gal4 and Gcn4 (9). The Med2, Med3, and Med15 proteins form a module (the Gal11 module), which in part may function as a separate entity. In cells lacking Med16, the Gal11 module is detached from Mediator and recruited as a separate entity to the ARG1 promoter by the yeast activator Gcn4 (10). Interestingly, this free Med2-Med3-Med15-containing complex recruits TBP and pol II to the promoter, and cells that lack Med16 show no defects in the induced expression levels of either of the two Gcn4-dependent ARG1 and SNZ1 genes, even though the middle or head module Mediator subunits cannot be detected at these promoters. It is possible that alternative activator-coactivator complex formations are functional at the ARG1 and SNZ1 genes and that the isolated tail module might interact with, for example, the SAGA or SWI/SNF complexes in a way that is sufficient for the assembly of a functional preinitiation complex.

We have characterized the Med5 protein here and demonstrate that it is a component of the Mediator tail domain. We find that the in vivo role of Med5 is related to the function of other components in the tail module. Med5 influences the regulated expression of nuclear encoded components of the oxidative phosphorylation (OXPHOS) machinery, and deletion of the MED5 gene affects both carbon source usage and oxygen consumption.


   MATERIALS AND METHODS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
Antibodies and Immunoblot Analyses—Synthetic polypeptides corresponding to amino acids 1-15 of Med5 were used to immunize rabbits. The antisera used in this study were taken 10 days after the second booster injection (Innovagen AB, Lund, Sweden). Immunoblot analysis for Mediator proteins was as described (3, 5). Other antibodies used in this study were kindly provided by Drs. R. A. Young (Med18 (Srb5) and Med20 (Srb2)), Y.-J. Kim (Med14 (Rgr1) and Med16), and A. Aguilera (Med3).

Recombinant Proteins—DNA fragments encoding S. cerevisiae Med2, Med3, Med5, Med15, and Med16 were amplified from genomic DNA. PCR products were cloned into the vectors pBacPAK8 or pBacPAK9 (Clontech). Autographa californica nuclear polyhedrosis viruses recombinant for the individual proteins were constructed as described in the BacPAK manual (Clontech). Spodoptera frugiperda (Sf9) cells were maintained and propagated in suspension in SFM 900 medium (Invitrogen) containing 5% fetal calf serum at 27 °C. For protein expression, Sf9 cells were grown in suspension and harvested 60-72 h postinfection. Infected cells were frozen in liquid nitrogen and thawed at 4 °C in lysis buffer containing 25 mM Tris-HCl, pH 8.0, 20 mM {beta}-mercaptoethanol, and 1x protease inhibitors (for all purifications a 100x stock of protease inhibitors contained 100 mM phenylmethylsulfonyl fluoride, 200 mM pepstatin A, 60 mM leupeptin, and 200 mM benzamidine in 100% ethanol). The cells were incubated on ice for 20 min, transferred to a Dounce homogenizer, and disrupted using 20 strokes of a tight-fitting pestle. NaCl was added to a final concentration of 1.5 M, and the homogenate was swirled gently for 40 min at 4 °C. The extract was cleared by centrifugation at 45,000 rpm for 45 min at 4 °C using a Beckman TLA 100.3 rotor.

Protein Purification—Purification of the RNA pol II holoenzyme and mutant versions thereof was as described previously (9). For purification of the Med2-Med3 dimer, Sf9 cells were co-infected with recombinant baculoviruses expressing Med2 and Pgd1 at a multiplicity of infection of 10 for each virus. After lysis and centrifugation, the supernatant was dialyzed against buffer Q-0.1 (20 mM Tris acetate, pH 7.8, 0.2 mM EDTA, 10% glycerol, 1 mM dithiothreitol, and 1x protease inhibitors; the number after the hyphen (e.g. Q-0.1) indicates the potassium acetate concentration in molar units) overnight. The dialyzed material was loaded on a Mono Q 5/5 FPLC column (Amersham Biosciences), which had been equilibrated in buffer Q-0.1. The column was washed with 5 ml of buffer Q-0.1 and eluted by a linear gradient (15 ml) of buffer Q-0.1-1.0. The Med2-Pgd1 dimer eluted at about 700 mM KAc. The eluate was dialyzed against buffer A-0.08 (25 mM Hepes-KOH, pH 7.6, 10% (v/v) glycerol, 1 mM EDTA, 1 mM dithiothreitol, and 1x protease inhibitors; the number after the hyphen (e.g. A-0.08) indicates the potassium acetate concentration in molar units) overnight. The dialyzed material was applied to a Mono S 5/5 column (Amersham Biosciences) that had been equilibrated in buffer A-0.1. The column was washed with 5 ml of buffer A-0.1, and proteins were eluted with a linear gradient (15 ml) of buffer A-0.1-1.0. A peak of the Med2-Med3 dimer eluted around 0.45 M KAc. The peak fractions were dialyzed against buffer H-0.07 (20 mM K·PO4, pH 7.6, 10% glycerol, 1 mM dithiothreitol, and 0.2 mM EDTA, pH 8.0; the number after the hyphen (e.g. H-0.07) indicates the potassium acetate concentration in molar units) for 4 h and loaded on a 1-ml HiTrap heparin column (Amersham Biosciences) that had been equilibrated with buffer H containing 100 mM KAc. Essentially pure Med2-Med3 eluted around 0.40 M KAc. The peak fractions were frozen in liquid nitrogen and finally stored at -80 °C. For purification of the Med2-Med3-Med5-Med15 tetramer, Sf9 cells were co-infected with recombinant baculoviruses expressing all of these proteins at a multiplicity of infection of 5 for each virus. After lysis and centrifugation, the supernatant was dialyzed against buffer A-0.1. A 15-ml S-Sepharose FF (Amersham Bioscience) column was washed with 45 ml of buffer A-0.1, and proteins were eluted with a linear gradient (150 ml) of buffer A-0.1-1.0. A peak of the Med2-Med3-Med5-Med15 tetramer eluted around 0.45 M KAc. The peak fractions were dialyzed against buffer H-0.1 and loaded on a 1-ml HiTrap heparin column that had been equilibrated with buffer H containing 100 mM KAc. The Med2-Med3-Med5-Med15 tetramer eluted around 400 mM KAc. The peak fractions were frozen in liquid nitrogen and finally stored at -80 °C. To determine the apparent molecular weight of the Med2-Med3 dimer and the Med2-Med3-Med5-Med15 tetramer, a portion (0.5 ml) of the Mono S (Med2-Med3) or the heparin peak (Med2-Med3-Med5-Med15) was applied to a Superose 12 column (Amersham Biosciences) equilibrated in Q-0.2.

Affymetrix GeneChip Probe Array Analyses and Real-time PCR—Total yeast RNA was isolated using a hot acid phenol extraction protocol (11). Poly(A)+ RNA was prepared from total RNA using the Oligotex Midi Kit (Qiagen). The cDNA synthesis, cRNA synthesis, and labeling, as well as array hybridization to Affymetrix yeast S98 arrays, were performed at the Karolinska Institute Affymetrix core facility as described in the Affymetrix users' manual (30). Washing and staining of arrays were performed using the GeneChip Fluidics Station 400 and by scanning with the Affymetrix GeneArray scanner. Acquisition and quantification of array images as well as primary data analysis were performed using Affymetrix GeneChip operating software (GCOS) 1.2. The transcription analysis was performed with RNA prepared from two wild type and two med5{Delta} cell cultures. Each of the two wild type RNA preparations was compared with both of the med5{Delta} RNA preparations, generating a total of four comparisons. Genes absent according to the Affymetrix detection algorithm on both arrays of a comparison were excluded from the presented data. Genes were included if the Affymetrix change algorithm gave significant change calls (p < 0.0025) in all four comparisons. To verify changes in gene transcription, real-time quantitative PCR was carried out on ABI Prism 7700 sequence detection system with Absolute QPCR SYBR Green reagents (Applied Biosystem) and primers at a concentration of 0.5 µM. PCR conditions were standardized to 40 cycles: 95 °C for 15 s followed by 60 °C for 1 min. The -fold change reported in TABLE THREE is the average of at least three separate experiments. Primer sequences are available upon request.


View this table:
[in this window]
[in a new window]
  		TABLE THREE
Genes affected in a med5{Delta} strain Shown are genes in which expression is most affected in a med5{Delta} strain as compared with the wild type. The -fold change is given as an average of all four comparisons. For expression analysis, we used the Affymetrix yeast S98 arrays as described under "Materials and Methods." Some of the changes in gene transcription were verified with real-time quantitative PCR, and real-time fold changes (RT/FC) from these experiments are indicated in the table. GPI, glycosylphosphatidylinositol.

 
Yeast Strains and Genetic Manipulations—Yeast strains used in this study are listed in TABLES ONE and TWO. For disruption of MED5, the KanMX4 cassette was amplified from Y04518 (med5::KanMX4) with primers binding to sequences 500 bp upstream and downstream of the cassette. The KanMX4-containing DNA fragment was used to construct the JB001 and JB002 strains using standard genetics methods (12, 13). The Y04393, Y01742, Y01976, Y04518, and Y13701 [GenBank] strains were from the Euroscarf collection. A MED5-encoding DNA fragment was amplified from the yeast strain W303-1A including 500 bp upstream and downstream of the open reading frame by PCR (forward primer: 5'-CCGGGGATCCTTTCCATATCTCCTAATGGT-3'; reverse primer: 5'-CCGGCCCGGGCCGCAGCTGACACTGTTATA-3'). The MED5-encoding fragment was digested with BamHI and SmaI and subsequently cloned into the pHR81 vector (20).


View this table:
[in this window]
[in a new window]
  		TABLE ONE
Yeast strains congenic to W303-1A These strains carry the SUC2 ade2-1 can 1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 markers.

 


View this table:
[in this window]
[in a new window]
  		TABLE TWO
Yeast strains Y04393, Y01742, Y01976, Y04734, and Y00518 [GenBank] congenic to BY4741 and strain Y13701 [GenBank] congenic to BY4742

 
Growth Curves and Measurements of Respiration Rates—Yeast strains grown in YPD (1% yeast extract, 2% peptone, 2% dextrose) were used as inocula. Exponentially growing cells were collected by centrifugation, and the pellet was washed once with water and once with YPG (1% yeast extract, 2% peptone, 3% glycerol). The cultures were diluted with YPG to an initial OD of 0.1-0.2, and the growth was monitored by OD measurements for ~60 h.

For measurements of respiration rates, cells were grown exponentially for 12-24 h in synthetic complete (SC) medium (yeast nitrogen base supplemented with ammonium sulfate (Qbiogene catalog no. 4027-512), 2% glucose, and amino acids). The cultures were then diluted to OD 0.1-0.15, and respiration was measured after 2-3 generations. Oxygen consumption in whole cells was measured using a Clarke electrode connected to a CB1-D3-02 control box (Hansatech, KingsLynn, United Kingdom). Exponentially growing cells were harvested by centrifugation at 1800 rpm in a clinical centrifuge (Jouan CR422) and washed once with water and twice with 40 mM NaPO4, pH 7.4. We estimated the cell count using a Bürker counting chamber.

The respiration rate was measured at 30 °C by adding 2.5 x 107 cells to a water-jacked chamber containing 1 ml of 40 mM NaPO4, pH 7.4, with 1% glucose added as substrate. Cyanide-sensitive respiration was calculated after the addition of 1 mM KCN when the cyanide-insensitive respiration was subtracted from the total respiration. Measurements were repeated at least three times for each individual strain.

Measurement of Citrate Synthase Activity and Mitochondrial Volume Density—Exponentially growing cells (OD 0.5-0.8) in SC-glucose medium were harvested by centrifugation at 1800 rpm and +4°C in a clinical centrifuge (Jouan CR422) and washed once with water followed by two washes with buffer J (0.138 M NaCl, 2.7 mM KCl, 0.01 M Na·PO4, pH 7.4, 1 M sorbitol). Approximately 108 cells were resuspended in 0.6 ml of buffer J and incubated with 400 units of lyticase at 30 °C for 50-60 min to digest the cell wall. Spheroplasts were collected by centrifugation, washed twice with buffer J, and frozen at -20 °C. Citrate synthase activity was determined in triplicate for each strain as described previously (14, 15). Volume density measurements of mitochondria on electron micrographs were performed as described previously (16). Twenty-five randomly selected cells from each strain were selected for analysis.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
Med5 Is a Component of the Mediator Tail Module—We and others have reported previously that the Med5 protein is present in highly purified preparations of the S. cerevisiae Mediator complex (5, 17). To further verify that Med5 is a stable component of Mediator, we raised polyclonal antibodies against a synthetic peptide corresponding to the N-terminal 15 amino acids of Med5. The Med5 protein co-purified with Mediator on Bio-Rex70, DEAE-Sepharose FF, hydroxyapatite, Mono Q, and Superose 6. Immunoblot analysis showed co-elution from Superose 6 of Med5 with Med2 and Med20 (Fig. 1A).



View larger version (46K):
[in this window]
[in a new window]
  		FIGURE 1.
A, Med5 is stably associated with Mediator during gel filtration. The gel filtration step was performed using a Superose 6 column at high ionic strength to minimize nonspecific protein-protein interactions. Fractions were analyzed by 10% SDS-PAGE and immunoblotted with antibodies directed against different Mediator subunits as indicated in the figure. B, Mono Q fractions of pol II holoenzymes prepared from wild type (WT), med2{Delta}, med3{Delta}, and med15{Delta} cells were subjected to immunoblot analysis using antibodies directed against individual Mediator subunits, as indicated in the figure. C, Mono Q fractions of pol II holoenzymes prepared from wild type (lane 3) and med16{Delta} (lane 4) cells were subjected to immunoblot analysis using antibodies directed against Med5, Med2, and Med4. For comparison, wild type holoenzymes diluted 1:2 and 1:4 were also analyzed (lanes 1 and 2). D, Mediator from the med5{Delta} mutant migrates as a single complex on a Mono S column. Fractions were analyzed by 10% SDS-PAGE and immunoblotted with antibodies directed against different proteins, as indicated in the figure.

 
Several nonessential Mediator subunits (Med2, Med3, Med15, and Med16) have previously been localized to the Mediator tail module, and we therefore investigated the presence of Med5 in Mediator purified from med2{Delta}, med3{Delta}, med15{Delta}, and med16{Delta} mutant strains. We found Med5 present in Mediator from the med2{Delta}, med3{Delta}, and med15{Delta} strains, demonstrating that Med5 does not depend on any of the encoded proteins for stable interaction with the rest of the Mediator (Fig. 1B). Analysis of Mediator from the med16{Delta} strain did, however, not only reveal a loss of the known Gal11 module proteins, as reported previously (9), but also a loss of Med5 (Fig. 1C). We therefore conclude that Med5 is a new component of the Mediator tail module and that it is located peripherally to Med16, together with subunits of the Gall11 submodule. Our attempts to purify Mediator from a med5{Delta} strain and analyze its subunit composition proved difficult, because the mutant Mediator complex precipitated during later stages of protein purification. We could however use immunoblot analysis to demonstrate that the med5{Delta} mutant Mediator purified as a multiprotein complex, which still contained the other tail module components Med2 and Med16 (Fig. 1D).

Med5 Interacts with the Gal11 Module—We constructed recombinant baculoviruses for expression of Med2, Med3, Med5, Med15, and Med16 and investigated the association of these subunits by co-expression in insect cells. When Med2 and Med3 are expressed together, they form a soluble complex that can be purified to near homogeneity. Gel filtration analysis demonstrated that the Med2-Med3 complex had an apparent molecular weight of about 90 kDa, suggesting that the two proteins form a stable dimer with a molar ratio of 1:1 (Fig. 2A). Med15 was insoluble even when co-expressed with the Med2-Med3 complex, and we therefore could not demonstrate the existence of a separate Med2-Med3-Med15 subcomplex. Similarly, Med5 was insoluble when expressed on its own (data now shown), but co-expression of Med5 with Med2, Med3, and Med15 generated a soluble tetrameric complex that could be purified as a single entity over Mono S and heparin-Sepharose FF (Fig. 2B, data not shown). Gel filtration chromatography indicated that the Med2-Med3-Med5-Med15 complex had a size of about 500 kDa, roughly corresponding to the combined molecular masses of the four proteins (Fig. 2C). Our experiments demonstrated that a Med2-Med3-Med5-Med15 complex can be formed in vitro, which is consistent with the existence of a distinct Gal11 module. On the basis of our biochemical analysis, we propose a structural model of the mediator tail domain in which Med5 is localized peripherally to Med16 and in complex with Med2, Med3, and Med15 (Fig. 2D).



View larger version (27K):
[in this window]
[in a new window]
  		FIGURE 2.
Protein complexes formed by co-expression of recombinant Mediator subunits in insect cells. A, Med2 and Med3 form a soluble dimer that can be purified to homogeneity. Peak fractions from a Superose 12 column (Amersham Biosciences) were analyzed by 12% SDS-PAGE. Proteins were stained with Coomassie Brilliant Blue. B, Med2, Med3, Med15, and Med5 that had been co-expressed in insect cells from a complex that co-migrates on an S-Sepharose column. Fractions were analyzed by 10% SDS-PAGE and immunoblotted with antibodies directed against the different proteins, as indicated in the figure. C, the peak from the S-Sepharose column was further fractionated by gel filtration on a Superose 12 column. Fractions were analyzed as described in B. D, proposed organization of the S. cerevisiae Mediator tail module.

 



View larger version (33K):
[in this window]
[in a new window]
  		FIGURE 3.
Genetic and phenotypic characterization of med5{Delta}. A, MED5 interacts genetically with MED21. Tetrads were dissected from a cross of strain H1310 (med21-ts) and JS004 (med5{Delta}::URA3). Surviving spore colonies were genotyped as indicated in the figure. U, Ura+ (med5{Delta}::URA3); ts, temperature-sensitive (med21-ts); Wt, wild type. Note that predicted double mutants are all dead. B, MED5 interacts genetically with MED15. The med5{Delta}/med15{Delta} double mutant is temperature-sensitive on YPD at 36 °C. The intact MED5 gene restores growth at 36 °C when present on a plasmid (pMED5). WT, wild type. C and D, deletion of MED5, MED16, or CYCC causes increased growth, whereas deletion of ELP3, GCN5, or MED15 causes decreased growth on rich glycerol medium (YP-Glycerol). After an initial lag period, a med1{Delta} strain also displayed increased growth. Growth was monitored by OD measurements for ~60 h.

 
Genetic Interactions of MED5 with MED15 and MED21—We next monitored genetic interactions between MED5 and genes encoding other Mediator subunits. We found a synthetic lethality between the med5{Delta} knock-out and med21-ts (Fig. 3A). The latter allele, which is temperature-sensitive at 38 °C, encodes an N-terminally truncated Med21 protein that lacks amino acid residues 2-8.4 We also found a synthetic interaction between the med5{Delta} and med15{Delta} knock-outs. The med5{Delta} med15{Delta} double knock-out strain is temperature-sensitive at 35 °C, as compared with 38 °C for the med15{Delta} strain and no temperature sensitivity for the med5{Delta} strain (Fig. 3B). No synthetic interaction was observed between the med5{Delta} and med16{Delta} knock-outs (data not shown), which is consistent with the finding that loss of Med16 also leads to loss of Med5 (Fig. 1C) and supports a localization of Med5 peripherally to Med16 (Fig. 2D).



View larger version (21K):
[in this window]
[in a new window]
  		FIGURE 4.
Mediator tail module mutants display increased respiration and mitochondrial activity. A, oxygen consumption was measured at 30 °C as described under "Materials and Methods." The respiration rates are given as -fold change compared with the wild type strain (WT). The bars indicate mean ± S.D. B, citrate synthase (CS) activity was measured as described under "Material and Methods." The bars indicate mean ± S.D. The activities are given as -fold change compared with the wild type strain. C, mitochondrial volume density (the mitochondrial volume fraction in the cytoplasm) in wild type, med5{Delta}, and med16{Delta} strains. The bars indicate mean ± S.E.

 
med5{Delta} Strain Displays Increased Respiration—The med2{Delta}, med3{Delta}, med15{Delta}, and med16{Delta} strains all exhibit gal- phenotypes, whereas the med5{Delta} strain is gal+ (data not shown). This is consistent with our observation that Med5 is not required for association of the Gal11 module with Mediator (Fig. 1D). Interestingly, the med5{Delta} strain grows significantly better than the wild type strain on the nonfermentable carbon source glycerol (Fig. 3C and data not shown). Enhanced growth on glycerol was also seen for some other Mediator mutant strains, including med16{Delta}, med1{Delta} and cycC{Delta}. In contrast, deletion of MED15, GCN5 (encoding a component of the SAGA complex), or ELP3 (encoding a component of the Elongator complex) produced a slow growth phenotype (Fig. 3, C and D). We also compared oxygen consumption in wild type and mutant yeast strains using a Clarke electrode. The med5{Delta} deletion caused a near 2-fold increase in oxygen consumption compared with a wild type strain (Fig. 4A). Other Mediator mutants, including med1{Delta}, med16{Delta}, and cycC{Delta}, also caused increased oxygen consumption, whereas the consumption dropped below that of the wild type in the gcn5{Delta} and elp3{Delta} strains. The enhanced growth on glycerol and increased oxygen consumption, suggested an increased respiratory activity in some of the Mediator mutant strains. Citrate synthase is one of the key enzymes in the tricarboxcylic cycle, and citrate synthase activity is used as an indicator of mitochondrial mass in eukaryotic cells. We compared citrate synthase activity in the wild type, med5{Delta}, and med16{Delta} strains. The citrate synthase activity was increased in the Mediator mutant strains and correlated well with the previously determined oxygen consumption (Fig. 4B). We also performed volume density measurements of mitochondria on electron micrographs and observed increased mitochondrial density in the med5{Delta} and med16{Delta} strains (Fig. 4C).

Med5 Influences Expression of Nuclear and Mitochondrial OXPHOS Genes—We next used DNA chip technology to identify genes that are dependent on Med5 for their expression. We compared med5{Delta} and wild type strains grown in YPD and observed no significant changes in global gene transcription (data now shown). When the cells were grown in synthetic complete glucose medium (SC-glucose), we saw dramatic changes in global gene transcription, and distinct functional patterns emerged. The three most affected genes were ANB1, DAN1, and TIR1, which displayed an almost 10-fold decrease in transcription (TABLE THREE). These genes belong to the group of anaerobic genes, which are induced in anaerobic cells and repressed in aerobic cells. The DAN/TIR genes encode homologous mannoproteins, which contribute to the anaerobic remodeling of the cell wall (18, 19), whereas ANB1 encodes an anaerobic isoform of translation initiation factor eIF-5A (21). We also noted an up-regulation of MUC1 (FLO11), a cell surface glycoprotein required for diploid pseudohyphal formation and haploid invasive growth (20, 21). In agreement with these changes in MUC1 gene transcription, scanning electron microscopy revealed a weak chain-forming phenotype for both the med5{Delta} and med16{Delta} strains (data not shown).

Finally we observed changed expression for a large number of genes encoding components involved in oxidative phosphorylation. No less than 32 nuclear encoded OXPHOS genes were significantly up-regulated in the med5{Delta} strain, and only one single nuclear OXPHOS gene was down-regulated. The down-regulated gene was COX5b, which encodes an anaerobically expressed isoform of the cytochrome-c oxidase subunit V. The COX5a gene, which encodes the aerobically expressed isoform of the same cytochrome-c oxidase subunit, was up-regulated in the med5{Delta} strain. The observed expression pattern is therefore consistent with the increased respiration observed in the med5{Delta} strain. In contrast to the nuclear genes, which were up-regulated, transcription of the mitochondrial OXPHOS genes AAP1, COX2, COX3, ATP6, and COB was down-regulated. Expression of nuclear and mitochondrial OXPHOS genes are coordinated in wild type cells, and the opposite effects observed in the med5{Delta} strain were therefore unexpected.


   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
We here identify Med5 as a structural component of the Mediator tail domain. Deletion of the MED16 gene leads to a loss of Med5 from the purified Mediator complex along with the Gal11 module components Med2, Med3, and Med15. Consistent with the idea that Med5 resides on the periphery of Med16 together with the Gal11 module, the four proteins form a soluble complex when co-expressed in insect cells. The localization of Med5 to the tail domain is also supported by the in vivo interactions between Med5 and Med16 observed in a recent yeast two-hybrid screen (22).

On the basis of our biochemical characterization, we postulate a model for the Mediator tail domain subunit architecture (Fig. 2D). To support the model, we investigate the functional importance of Med5 and its genetic interactions with other tail module subunits. We found that med5{Delta} and med15{Delta} interact genetically (Fig. 3B) but failed to observe genetic interactions between med5{Delta} and med16{Delta} (data not shown). The former observation supports a physical interaction between Med5 and Med16, whereas the latter is consistent with the biochemical finding that Med5 is lost in the med16{Delta} Mediator. We further found that a temperature-sensitive MED21 allele (med21-ts) is lethal in the med5{Delta} background (Fig. 3A) This observation is in nice agreement with a previous report of synthetic lethality between the temperature-sensitive MED10 allele nut2-ts70 and a med5{Delta} knock-out (6). Med10 and Med21 are both part of the middle domain of Mediator (26) and interact both genetically and physically with each other.4 The reason why Med5, which is normally dispensable, becomes an essential protein in the med21-ts and nut2-ts70 mutants remains to be determined. Possibly, Med5 participates in protein-protein interactions that help to stabilize the middle domain in these mutants.

Med5 interacts with the Gal11 module but is not absolutely required for the structural integrity of this module in vivo. Mediator purified from a med5{Delta} strain still retains the Gal11 module (Fig. 1D), and whereas deletion of MED2, MED3, or MED15 generates a gal- phenotype, the med5{Delta} and med16{Delta} strains remain gal+ (data not shown). Furthermore, it appears that Med5 is structurally and functionally more related to Med16 than to the other subunits of the tail module. First, Med5 is lost from Mediator purified from a med16{Delta} strain (Fig. 1B). Second, the med5{Delta} and med16{Delta} mutants have similar phenotypic characteristics with increased growth on the nonfermentable carbon source glycerol, increased oxygen consumption, and increased citrate synthase activity. We further found that loss of the entire Gal11 module (med15{Delta}) generates a dramatic chain-forming phenotype with grape-like clusters, whereas the med5{Delta} and med16{Delta} strains showed only a mild chain-forming phenotype. Med14 is thought to link the Mediator tail and middle domains, and a similar chain-forming phenotype has been reported for med14 mutant strains (23). Finally, MED16 functions as a negative regulator of HO gene expression, and both the MED5 and MED16 genes were isolated in a screen for mutants that would suppress the Swi4/Swi6 dependence of a synthetic reporter gene containing part of the HO promoter (6). In this context, it should be noted that deletion of the MED16 gene influences chromatin structure (24). The mechanisms remain obscure, but because the Med5 protein is an active acetyltransferase (5), it may be involved. Unfortunately, mutations in the Med5 HAT motif destabilize the protein,5 and we have therefore been unable to characterize the specific contribution of the HAT activity for Med5 function.

Our data suggest that deletion of MED5 causes an increased expression of nuclear encoded mitochondrial proteins that are involved in oxidative phosphorylation and a simultaneous down-regulation of genes that are encoded by the mitochondrial genome. The exact mechanisms for this uncoupling of nuclear and mitochondrial gene regulation remain elusive. Most nuclear encoded aerobic genes are subjected to glucose repression, and it is therefore possible that a deletion of MED5 leads to release from glucose repression similar to what has been reported for med14 (rgr1) and med16 mutations (25). Arguing against this possibility, we could not observe any increase in transcription of classical glucose repressed genes, e.g. SUC2, GAL1 or CYB2. Another possibility is that Med5 is involved in the retrograde response, a signaling pathway that communicates information from the mitochondria to the nucleus and affects many cellular processes including stress response, metabolic pathways, and mitochondrial biogenesis (26). Interestingly, the PGD1 gene, encoding the tail module protein Med3, was originally identified as a multicopy suppressor of a mutant mitochondrial RNA polymerase (27).

Finally, our finding that the med5{Delta} knock-out has only limited effects on gene transcription in YPD, but dramatic effects in synthetic complete medium, suggests that the growth conditions may influence the activity of or the requirements for Med5. It should be noted that the Ca2+ concentration in synthetic complete medium (900 µM) is significantly higher than in YPD (140 µM) (28). This difference in Ca2+ levels may be significant, because mitochondria-to-nucleus stress signaling occurs through elevated levels of cytosolic Ca2+ in mammalian cells (29). In future studies we will investigate the HAT activity of the Med5 protein and how this activity is influenced by mitochondrial stress.


   FOOTNOTES
 
* This work was supported by grants from the Swedish Cancer Society (to C. M. G.), the Swedish Research Council (to H. R. and C. M. G.), the Swedish Foundation for Strategic Research (to C. M. G.), the European Commission (fp6 EUMITOCOMBAT) (to C. M. G.), and the Erik and Mai Pehrsson Foundation (to H. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

1 Current address: Dept. of Genetics, Cell Biology, and Development, University of Minnesota, 6-160 Jackson Hall, 321 Church St. S.E., Minneapolis, MN 55455. Back

2 To whom correspondence should be addressed: Karolinska Institute, Division of Metabolic Diseases, Novum, SE-141 86 Stockholm, Sweden, Tel.: 46-8-585-83974; Fax: 46-8-779-5383; E-mail: claes.gustafsson{at}ki.se.

3 The abbreviations used are: pol II, polymerase II; OXPHOS, oxidative phosphorylation; HAT, histone acetyltransferase. Back

4 M. Hallberg, G.-Z. Hu, D. Balciunas, Z. Shaikhibrahim, S. Björklund, and H. Ronne, manuscript submitted for publication. Back

5 J. Béve, unpublished observation. Back


   ACKNOWLEDGMENTS
 
We thank Dr. David Stillman for the gift of DY1699 (to H. R.) and Dr. Jesper Svejstrup for the gift of JS004, JS005, and JS006 (to C. M. G.).



   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Myers, L. C., and Kornberg, R. D. (2000) Annu. Rev. Biochem. 69, 729-749[CrossRef][Medline] [Order article via Infotrieve]
  2. Kim, Y. J., Bjorklund, S., Li, Y., Sayre, M. H., and Kornberg, R. D. (1994) Cell 77, 599-608[CrossRef][Medline] [Order article via Infotrieve]
  3. Myers, L. C., Gustafsson, C. M., Bushnell, D. A., Lui, M., Erdjument-Bromage, H., Tempst, P., and Kornberg, R. D. (1998) Genes Dev. 12, 45-54[Abstract/Free Full Text]
  4. Lorch, Y., Beve, J., Gustafsson, C. M., Myers, L. C., and Kornberg, R. D. (2000) Mol Cell 6, 197-201[CrossRef][Medline] [Order article via Infotrieve]
  5. Gustafsson, C. M., Myers, L. C., Beve, J., Spahr, H., Lui, M., Erdjument-Bromage, H., Tempst, P., and Kornberg, R. D. (1998) J. Biol. Chem. 273, 30851-30854[Abstract/Free Full Text]
  6. Tabtiang, R. K., and Herskowitz, I. (1998) Mol. Cell. Biol. 18, 4707-4718[Abstract/Free Full Text]
  7. Asturias, F. J., Jiang, Y. W., Myers, L. C., Gustafsson, C. M., and Kornberg, R. D. (1999) Science 283, 985-987[Abstract/Free Full Text]
  8. Dotson, M. R., Yuan, C. X., Roeder, R. G., Myers, L. C., Gustafsson, C. M., Jiang, Y. W., Li, Y., Kornberg, R. D., and Asturias, F. J. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 14307-14310[Abstract/Free Full Text]
  9. Myers, L. C., Gustafsson, C. M., Hayashibara, K. C., Brown, P. O., and Kornberg, R. D. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 67-72[Abstract/Free Full Text]
  10. Zhang, F., Sumibcay, L., Hinnebusch, A. G., and Swanson, M. J. (2004) Mol. Cell. Biol. 24, 6871-6886[Abstract/Free Full Text]
  11. Schmitt, M. E., Brown, T. A., and Trumpower, B. L. (1990) Nucleic Acids Res. 18, 3091-3092[Free Full Text]
  12. Rothstein, R. (1991) Methods Enzymol. 194, 281-301[CrossRef][Medline] [Order article via Infotrieve]
  13. Sherman, F. (1991) Methods Enzymol. 194, 3-21[CrossRef][Medline] [Order article via Infotrieve]
  14. Wibom, R., Hagenfeldt, L., and von Dobeln, U. (2002) Anal. Biochem. 311, 139-151[CrossRef][Medline] [Order article via Infotrieve]
  15. Wredenberg, A., Wibom, R., Wilhelmsson, H., Graff, C., Wiener, H. H., Burden, S. J., Oldfors, A., Westerblad, H., and Larsson, N. G. (2002) Proc. Natl. Acad. Sci. U. S. A. 99, 15066-15071[Abstract/Free Full Text]
  16. Ekstrand, M. I., Falkenberg, M., Rantanen, A., Park, C. B., Gaspari, M., Hultenby, K., Rustin, P., Gustafsson, C. M., and Larsson, N. G. (2004) Hum. Mol. Genet. 13, 935-944[Abstract/Free Full Text]
  17. Liu, Y., Ranish, J. A., Aebersold, R., and Hahn, S. (2001) J. Biol. Chem. 276, 7169-7175[Abstract/Free Full Text]
  18. Sertil, O., Cohen, B. D., Davies, K. J., and Lowry, C. V. (1997) Gene (Amst.) 192, 199-205[CrossRef][Medline] [Order article via Infotrieve]
  19. Abramova, N. E., Cohen, B. D., Sertil, O., Kapoor, R., Davies, K. J., and Lowry, C. V. (2001) Genetics 157, 1169-1177[Abstract/Free Full Text]
  20. Lo, W. S., and Dranginis, A. M. (1998) Mol. Biol. Cell 9, 161-171[Abstract/Free Full Text]
  21. Lo, W. S., and Dranginis, A. M. (1996) J. Bacteriol. 178, 7144-7151[Abstract/Free Full Text]
  22. Guglielmi, B., van Berkum, N. L., Klapholz, B., Bijma, T., Boube, M., Boschiero, C., Bourbon, H. M., Holstege, F. C., and Werner, M. (2004) Nucleic Acids Res. 32, 5379-5391[Abstract/Free Full Text]
  23. Sakai, A., Shimizu, Y., Kondou, S., Chibazakura, T., and Hishinuma, F. (1990) Mol. Cell. Biol. 10, 4130-4138[Abstract/Free Full Text]
  24. Jiang, Y. W., and Stillman, D. J. (1992) Mol. Cell. Biol. 12, 4503-4514[Abstract/Free Full Text]
  25. Wang, X., and Michels, C. A. (2004) Genetics 168, 747-757[Abstract/Free Full Text]
  26. Butow, R. A., and Avadhani, N. G. (2004) Mol. Cell 14, 1-15[CrossRef][Medline] [Order article via Infotrieve]
  27. Brohl, S., Lisowsky, T., Riemen, G., and Michaelis, G. (1994) Yeast 10, 719-731[CrossRef][Medline] [Order article via Infotrieve]
  28. Muller, E. M., Locke, E. G., and Cunningham, K. W. (2001) Genetics 159, 1527-1538[Abstract/Free Full Text]
  29. Biswas, G., Adebanjo, O. A., Freedman, B. D., Anandatheerthavarada, H. K., Vijayasarathy, C., Zaidi, M., Kotlikoff, M., and Avadhani, N. G. (1999) EMBO J. 18, 522-533[CrossRef][Medline] [Order article via Infotrieve]
  30. Affymetrix (2000) Affymetrix GeneChip Expression Analysis Technical Manual, Affymetrix, Santa Clara, CA

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 GENES CELLSHome page
H. Takahashi, K. Kasahara, and T. Kokubo
Saccharomyces cerevisiae Med9 comprises two functionally distinct domains that play different roles in transcriptional regulation
Genes Cells, January 1, 2009; 14(1): 53 - 67.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
H.-M. Bourbon
Comparative genomics supports a deep evolutionary origin for the large, four-module transcriptional mediator complex
Nucleic Acids Res., July 1, 2008; 36(12): 3993 - 4008.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
L. Lariviere, M. Seizl, S. van Wageningen, S. Rother, L. van de Pasch, H. Feldmann, K. Strasser, S. Hahn, F. C.P. Holstege, and P. Cramer
Structure-system correlation identifies a gene regulatory Mediator submodule
Genes & Dev., April 1, 2008; 22(7): 872 - 877.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. M. Baidoobonso, B. W. Guidi, and L. C. Myers
Med19(Rox3) Regulates Intermodule Interactions in the Saccharomyces cerevisiae Mediator Complex
J. Biol. Chem., February 23, 2007; 282(8): 5551 - 5559.
[Abstract] [Full Text] [PDF]

Home page
 GeneticsHome page
H. Singh, A. M. Erkine, S. B. Kremer, H. M. Duttweiler, D. A. Davis, J. Iqbal, R. R. Gross, and D. S. Gross
A Functional Module of Yeast Mediator That Governs the Dynamic Range of Heat-Shock Gene Expression
Genetics, April 1, 2006; 172(4): 2169 - 2184.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/50/41366    most recent
M511181200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Béve, J.
Right arrow Articles by Gustafsson, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Béve, J.
Right arrow Articles by Gustafsson, C. M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement